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ABSTRACT 
Introduction: Harm reduction involving partial or complete substitution of cigarettes with 
NRT (Nicotine Replacement Therapy) is likely to benefit smokers by reducing exposure to 
carcinogens and increasing the likelihood of permanent cessation. This paper aimed to assess 
the determinants of short and long-term NRT use for harm reduction in order to inform 
interventions aimed at helping smokers struggling to quit to switch to complete NRT 
substitution.  
Methods: Data were used from the Smoking Toolkit Study, a population based survey of 
adults in England aged 16+ (n=9,224). Participants were asked about their socio-demographic 
characteristics and tobacco use. Attitudes towards smoking were also assessed using 
questions covering four factors: motives, identity, evaluations and plans. 
Results: Concurrent short-term (<3 months) and longer-term (>=3 months) NRT use was 
uncommon among smokers at 10.8% (95%CI 10.1-11.4) and 5.0% (95%CI 4.6-5.4), 
respectively. Longer-term NRT users had higher odds of being older, in non-manual 
occupations and more addicted than smokers with short-term or no NRT use (all p<0.01). 
They reported lower odds of attempting to stop and higher odds of exhibiting a positive 
smoker identity than short-term users (p<0.001). Conversely, longer-term NRT users had 
higher odds of having made a recent quit attempt, to have plans to stop and lower odds of a 
positive smoker identity than smokers not using NRT (all p<0.001). 
Conclusion:  Whilst users of NRT for harm reduction purposes are a heterogeneous group, it 
appears they are more critical of smoking than never users and tend to positively modulate 
their behaviour, setting them on a path towards cessation. 
Abstract word count: 250. 
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INTRODUCTION 
Tobacco smoking remains one of the leading causes of preventable mortality and morbidity 
worldwide, accounting for 12% of all deaths globally among adults aged 30 years and over – 
(World Health Organisation, 2012). Consequently, although traditional tobacco control 
strategies, i.e. prevention and cessation, have proved effective, it has been argued that newer 
innovative strategies are needed to tackle the worldwide tobacco problem. One proposed 
approach is harm reduction, which involves any attempt to lessen the harm from smoking 
without complete cessation of one or more tobacco constituents (Beard, McNeill, Aveyard, 
Fidler, Michie, & West, 2011a).  
 
A specific type of harm reduction is the substitution of cigarettes with nicotine replacement 
therapy (NRT). This may be partial, i.e. use of NRT for smoking reduction (SR) or temporary 
abstinence (TA) when one is unable to smoke, or long-term, i.e. the complete substitution of 
cigarettes with medicinal nicotine products. In the UK NRT has been licensed for these 
purposes since 2005/2006 (MHRA, 2009) and guidance was released by the National 
Institute of Health and Care Excellence in 2013 which recommended that provisions be put in 
place for English Stop Smoking Services to extend their offer of support and guidance to 
smokers who are unable or unwilling to stop smoking and who were interested in harm 
reduction. 
 
Partial substitution was initially endorsed as a consequence of findings from clinical trials 
(Wang, Connock, Barton, Fry-Smith, Aveyard & Moore, 2008; Moore et al., 2009) and 
population based studies (Beard et al., 2011a) which suggest that the use of medicinal 
nicotine for such purposes increases smokers’ likelihood to quit, and in some cases, results in 
significant reductions in cigarette consmption and toxic intake; complete substitution is 
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advocated due to the acknowledgment that it is safer to use NRT than to smoke and that the 
long-term use of NRT is effective for preventing relapse following a quit attempt (Agboola, 
McNeill, Coleman, & Bee, 2010).  
 
While a substantial minority of smokers report that they are attempting harm reduction with 
the aid of NRT (Beard, Bruguera, Brown, McNeil, & West, 2013a), this does not appear to 
have been a consequence of recent licence changes, with a similar prevalence of NRT use for 
smoking reduction and temporary abstinence in England pre and post these adaptations 
(Shahab et al., 2009; Beard et al., 2013a). Indeed, most smokers are attempting SR and TA 
without pharmacological help (Beard et al, 2011a), and fail to use medicinal nicotine to 
prevent relapse following a quit attempt (Etter & Perneger, 2001). This might be due to 
various reasons, including lack of awareness of the licence change, concerns about the safety 
of medicinal nicotine or the cost of buying NRT concurrently with cigarettes (e.g. Basal et 
al., 2004; Beard et al., 2012a Carpenter, Ford, Cartmell, & Alberg, 2011). As attempts at SR, 
TA and cessation are more effective with the aid of medicinal nicotine (Moore et al., 2009) 
and given that switching fully to NRT is likely to be less harmful to health than continued 
smoking (Benowitz et al., 1998), there is a need to identify ways in which usage can be 
increased among current smokers. 
 
A suitable first step is the development of a typology of smokers who use NRT for harm 
reduction to identify their beliefs, characteristics and views. Previous work shows that 
smokers using NRT for SR or TA had suffered substantial difficulties with smoking 
cessation, relied heavily on NRT, were more dependent smokers and hostile towards stop 
smoking policies and services (Beard et al., 2012a; Beard et al., 2013b). 
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However, these studies occurred before many of the recent licensing changes and did not try 
to differentiate between smokers with different temporal usages of NRT. Consideration of 
these groups separately is important as smokers using NRT in the short-term may be 
qualitatively different and require different levels of support than those using NRT long-term. 
Understanding the beliefs and characteristics of users will help to inform future interventions 
aimed at encouraging smokers not only to switch to concurrent NRT use and partial 
substitution but, eventually, to complete substitution and stopping smoking.  
 
As a consequence, the current study attempts to devise a preliminary typology of smokers 
using NRT both short- and longer-term. We aim to identify ways to modify current smokers’ 
attitudes and behaviours in order to encourage harm reduction. Smokers were compared 
quantitatively in a population-based household survey to assess socio-demographic and 
attitudinal characteristics associated with NRT use and length of use to provide information 
about ways to encourage partial substitution.  
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METHODS 
Design and Procedure 
A quantitative study using data from the Smoking Toolkit Study (STS; 
www.smokinginengland.info), which provides up to date information on smoking behaviour 
and smoking cessation patterns among adult (aged 16+) smokers and recent ex-smokers in 
England. Further details of the design and method are described elsewhere (Fidler et al., 
2011). Data used for the current paper were obtained between August 2010 and April 2012. 
 
Measures 
Smoking status was assessed by asking: ‘Which of the following best applies to you? 
– (I smoke cigarettes (including hand-rolled) every day; I smoke cigarettes (including 
handrolled), but not every day; I do not smoke cigarettes at all, but I do smoke tobacco of 
some kind (for example: pipe or cigar); I have stopped smoking completely in the last year; I 
stopped smoking completely more than a year ago; I have never been a smoker (i.e. smoked 
for a year or more); don’t know). Those who responded that they smoked cigarettes every 
day, or that they smoked but not every day, were coded as current cigarette smokers. Current 
smokers were asked if they had used NRT and if they answered yes: ‘How long have you 
used nicotine replacement products for?’ – (Less than one week; one to six weeks; more than 
six weeks up to twelve weeks more than 12 weeks).’ Those who had used NRT for less than 
3 months were classified as short-term users and those who had used NRT for at least 3 
months as longer-term users. Participants were then further asked about harm reduction and 
NRT use. They were asked “Whether they are currently trying to cut down amount smoked"; 
“Whether they are attempting to cut down amount smoked but not currently trying to stop”; 
“Whether they are using products to help cut down the amount smoked” and “Whether they 
use products to cut down, stop smoking or for any other reason.” All smokers were also asked 
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various questions about their beliefs regarding smoking which were based on PRIME theory 
(West, 2006). Age, gender and social grade (classified as non-manual (ABC1) and manual 
(C2DE) using the NRS classification scale, see http://www.nrs.co.uk/lifestyle-data/) were 
measured, as was nicotine dependence (Heaviness of smoking index, Heatherton, Kozlowski, 
Frecker, Rickert, & Robinson, 1989), previous attempts to quit smoking, and attempts to cut 
down cigarette consumption. See http://www.smokinginengland.info for further details of the 
survey design and methodology.  
 
Participants 
Between August 2010 and April 2012, 9,328 smokers were recruited of whom 7% (n=104) 
were excluded due to missing data on NRT use. This resulted in a final sample of 9,224 
smokers: 70% (n=6,505) were in manual occupation, the mean age was 42 (SD+16.9) and 
48% (n=4,552) were women.  
 
Data Analysis 
Analysis was carried out using SPSS 20.0. Associations between the long-term use of NRT 
and socio-demographic, and smoking characteristics and beliefs, were assessed by logistic 
regression analyses, controlling for potential confounding variables age, gender, social grade, 
and time to first cigarette of the day, as appropriate. The 14 questions on beliefs about 
smoking were factorised following assessment for factorability: several of the items were 
corrected at 0.3 or above; the Kaiser-Meyer-Olkin was 0.69 (above the commonly 
recommended value of 0.6); Bartlett’s test of sphericity was significant (X2(91)=15173, 
p<0.001); and the diagonals of the anti-image correlation matrix were all over 0.5. Thus 
factor analysis was deemed suitable. Principle components analysis was used with oblique 
rotation as there was reason to believe that factors would be related to each other. A four 
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factors solution was identified, which explained 47.7% of the variance (Factor 1: 20.5%; 
Factor 2: 11.5%; Factor 3: 8.1%; and Factor 4: 7.6%). The four factors and factor loadings of 
the variables are given in Table 1. One of the variables “I have had enough of being a 
smoker” although loading better onto Factor 1 was moved to Factor 2 as this made greater 
theoretical sense. It loaded with -0.22 which is considered significant for the sample size. 
These factors were labelled using the constructs identified by PRIME theory (West, 2006): 
Factor 1 - Biopsychosocial prompts to stop (motives); Factor 2 - Positive smoker identity 
(identity); Factor 3 - Individual addiction (evaluations); and Factor 4 - Plans to stop (plans). 
Composite scores were created for each of the four factors with “I want to quit smoking”, “I 
have had enough of being a smoker”, “I am confident I could stop smoking if I tried” to and 
“I ought to stop smoking” being recoded so that higher scores were associated with more 
biopsychosocial prompts, a stronger smoker identity, greater perceived addiction and greater 
plans to stop. 
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RESULTS 
Nearly 16% (95%CI 15.0-16.5) of smokers (n=1,453) were concurrently using NRT: 5.0% 
(95%CI 4.6-5.4, n=460) had used NRT for at least 3 months (longer-term users) and 10.8% 
(95%CI 10.1-11.4, n=993) had used NRT for less than three months (short-term users).  
NRT users were a heterogeneous group and their characteristics differed as a function of 
length of use (see Table 2). Longer-term NRT users were older and more likely to be in a 
non-manual occupation compared with short-term NRT users and less likely to have made a 
recent quit attempt or to try cutting down. Whilst there were no differences in terms of 
biopsychosocial prompts to stop and plans to stop between longer and short-term users, 
smokers who used NRT for longer were generally more likely to harbour a positive smoker 
identity and to evaluate themselves as more addicted. 
 
As was the case when compared with short-term users, longer-term users were older and less 
likely to be in manual occupations than smokers who did not use NRT at all for harm 
reduction purposes. They were also more likely to be female and to exhibit higher 
dependence (Table 2). However, contrary to the comparison with short-term users, longer-
term users were more likely to have made a quit attempt and to try to cut down than smokers 
who did not use NRT and less likely to exhibit a positive smoker identity. They were more 
likely to report biopsychosocial prompts to stop and to evaluate themselves as more addicted. 
They were also more likely to have plans to stop smoking than smokers who did not use NRT 
at all (Table 2). 
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DISCUSSION 
This study aimed to develop a typology of long-term and short-term NRT users in order to 
inform interventions aimed at encouraging smokers who are unwilling to quit smoking to 
substitute their cigarettes with safer medicinal products.  
 
The analyses revealed that those using NRT longer-term were more likely to be being female, 
older and from non-manual occupations compared with smokers not using NRT. Despite 
appearing to be more nicotine dependent, NRT users had higher odds of having tried to 
change their smoking behaviour, i.e. to have made a quit attempt and/or cut down their 
cigarette consumption. In addition, longer-term users relative to non-users reported more 
environmental prompts to motivate them to change their behaviour and were less likely to 
exhibit a positive smoker identity. The findings demonstrate that concurrent NRT and 
cigarette users are a rather heterogeneous group. In particular, longer-term users were from 
higher socio-economic grades, were of an older age, were less likely to have tried to modify 
their smoking behaviour either through quitting or harm reduction and generally endorsed a 
more positive smoker identity. 
 
The finding that long-term NRT users tend to be of higher social-grade is unsurprising, since 
NRT use for harm reduction is generally obtained over the counter, rather than on 
prescription or free of charge (Hammond et al., 2008). This also likely explains the finding 
that longer-term NRT users were of higher social-grades than short-term users; with longer 
use equating to higher costs. Although this association with social-grade is consistent with 
previous studies (Beard et al., 2013b), it is of concern given that harm reduction approaches 
have been mooted as a means of reducing inequalities in smoking cessation. The recent NICE 
guidance on harm reduction acknowledged the issue of affordability, stating that “people may 
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be put off by the cost of some licensed nicotine-containing products” and that  “people may 
be at risk of relapse after their prescriptions for licensed nicotine-containing products run out 
if they find cigarettes are cheaper” (pp. 30-31). Therefore, consideration is required as to how 
costs may be driven down in addition to ensuring smokers are aware that in the long term, 
NRT use can be cheaper than continued smoking. A 7-day course of patches costs around 
£15, whilst on average £35 is spent on cigarettes by smokers each week. Thus even if 
smokers substitute only half their cigarettes for a full course of NRT, they would save on 
average 10 pounds a month (Davis, 2007).  
 
In line with previous studies (Moore et al., 2009; Beard et al., 2013b), we found that smokers 
using NRT concurrently are more motivated to quit smoking than non-NRT users. These 
findings are also consistent with the PRIME theory (West, 2006) as the constructs identified 
in the factor analysis (motives, identity, evaluations and plans) are related to this model, and 
revealed that NRT users were not only more motivated to quit, but they were also more likely 
to have plans to stop, and less likely to have a positive smoker identity. Accordingly, NRT 
users were more likely to have made more recent quit attempts than non-NRT users. Whilst 
the cross-sectional nature of this study means that causal inferences cannot be made, this 
finding is consistent with the view that NRT use may increase smokers’ propensity to quit by 
reducing withdrawal and craving symptoms which can lead smokers to believe that giving-up 
may not be uncomfortable (Fagerstrom, Schneider & Lunell, 1993). This may also increase 
smoker’s self-efficacy by helping them to learn that it is possible to cope without tobacco for 
several hours without undue discomfort. Yet, this findingmay also reflect the possibility that 
smokers who go on to use NRT concurrently are already more confident and motivated to 
stop at baseline. 
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However, on the basis of previous survey and clinical trial data, the former appears a more 
plausible argument as it has been shown that the concurrent use of NRT and cigarettes is 
associated with increased desire to quit smoking over time. For example, a recent prospective 
population study which matched participants on prior motivational levels using propensity 
score matching procedures reported that NRT use for harm reduction was associated with 
increased odds of attempting to quit smoking at 6 months (Beard et al., 2012b). Thus it might 
be argued that smokers who are unwilling or unable to quit smoking should be encouraged to 
use NRT in the hope that this will, at some point, induce an attempt to quit smoking. 
 
At the same time, our findings also point to the possibility that benefits are largest for short-
term users. The fact that longer-term NRT users were less motivated to quit smoking than 
short-term users could reflect dissipation of motivation to quit over time. Alternatively, 
selection bias may play a role, with less motivated smokers opting to use NRT long-term. Of 
course, the cross-sectional nature of the data complicates the picture as short-term users are 
likely to include both those using NRT short-term but will also consist of those who will go 
onto long-term use, resulting in a group that is overall less addicted and more likely to have 
plans to stop compared with longer-term users. As previously shown (Beard et al., 2013a), 
concurrent NRT use is associated with similar cigarette consumption compared with those 
not using NRT. However, if it is the case that long-term NRT users are slightly more nicotine 
dependent, then cross-sectional analyses may preclude any reduction in cigarette 
consumption, if smokers started at a higher cigarette level prior to reduction.  
 
Finally, the finding of greater NRT use among women and those of an older age gives some 
indication as to those who may be most receptive to a harm reduction approach and is 
perhaps unsurprising: men are generally less likely to seek preventative healthcare 
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(Courtenay, 2000), whilst older smokers hold greater positive beliefs about medications 
(Horne & Weinman, 1999). However, the fact that these findings largely coincide with 
studies on the characteristics of those using NRT for smoking cessation (Botello-Harbaum et 
al., 2010; Emmons et al., 2000; Kotz et al., 2009), raises the concern that harm reduction 
approaches are targeting those willing to quit smoking, as opposed to those unable or 
unwilling to do so. 
 
This study has a number of limitations. Firstly, being carried out in England where NRT is 
liberally licensed, the findings in this study cannot be generalised to other countries where 
NRT is not licensed for harm reduction. However it should be noted that the STS appears to 
be representative of the population as it has obtained similar demographic and smoking data 
to other large national surveys (Fidler et al., 2011). Secondly, as indicated above, data were 
cross-sectional in nature, which limits the conclusions that can be drawn in relation to the 
causal association between NRT use and motivation to quit smoking. Thirdly, despite careful 
wording of questions, the reliance on retrospective reports means that the current reasons for 
NRT use may differ from the reasons that first initiated NRT use, and may further differ from 
reasons for future NRT use. A longitudinal study following use of NRT over time may be 
better able to identify causality and associated changes in cognitions. A strength of this study 
is the fact that the analysis was theory-driven and findings are consistent with PRIME theory 
as the concepts that arose from the factor analysis were based on this model. 
 
Overall, this study has taken a first step in describing the attitudes, beliefs and characteristics 
of smokers with and without concurrent NRT use. We find that NRT users for harm reduction 
purposes are a heterogeneous group. However, irrespective of length of use, it appears they 
are more critical of smoking than never users, having greater awareness of various prompts to 
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stop, and hold a less positive smoker identity, resulting in greater modulation of their 
smoking behaviour with regards to quit attempts and cigarette consumption. Consequently, 
although NRT use may not necessarily lead to complete substitution, it helps to develop 
motivation and change perception about smoking towards a cessation trajectory. Crucially, 
however, the financial implications of NRT use may prevent those most in need of support 
from accessing it. Future interventions should aim to target specific characteristics to 
motivate and encourage smokers to use NRT, including provision of subsidised NRT for 
harm reduction purposes, provide them with support to maintain their motivation, and 
encourage quit attempts in order to achieve complete substitution. Lastly, given the 
limitations of cross-sectional analyses, further longitudinal research is warranted to confirm 
these findings. 
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TABLES 
Table 1: The four identified factors from the principle components analysis with factor loadings 
Factor 1: Biopsychosocial prompts to stop 
I am worried that smoking is harming my health right now (0.65) 
I am worried about the effect of smoking on my family and loved ones (0.62) 
I am worried smoking will harm my health in the future (0.61) 
It is getting too difficult to smoke these days  (0.56) 
People I care about want me to stop smoking (0.53) 
Smoking is costing me too much money  (0.44) 
I have had enough of being a smoker (0.61) 
******************************************************************************************************************* 
Factor 2: Positive smoker identity 
I enjoy smoking (0.68) 
I like being a smoker (0.63) 
I want to stop smoking (0.56) 
******************************************************************************************************************* 
Factor 3: Individual addiction 
I am confident I could stop smoking if I tried (0.68) 
I am addicted to smoking (-0.58) 
******************************************************************************************************************* 
Factor 4: Plans to stop 
I ought to stop smoking (0.68) 
I intend to stop smoking soon (-0.86) 
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Table 2: Socio-demographic and smoking characteristics and beliefs of participants as a function of NRT use 
#
Unless otherwise indicated; ^ Controlling for age, sex, occupation and time to first cigarette where appropriate; Note: LT = Long-term (NRT use ≥3 months); ST = 
Short-term (NRT use <3 months); *** significant difference p<0.001; ** significant difference p<0.01; * significant difference p<0.05. 
 
Overall ( 
n=9224) 
Smokers LT 
NRT 
(n=460) 
Smokers ST 
NRT 
(n=993) 
Smokers no 
NRT 
(n=7771) 
LT NRT versus ST 
NRT^ 
LT NRT versus no NRT^ 
 % (N)
#
 Odds ratio (95% CI) 
Socio-demographic characteristics      
Age  M(SD) 42.4 (16.9) 46.4 (16.1) 40.7 (15.0) 42.3 (17.1) 1.02*** 1.02-1.03 1.04*** 1.01-1.02 
Female %(n) 48.7 (4496) 53.0 (244) 52.0 (516) 48.1 (3736) 1.00 0.80-1.25 1.24* 1.00-1.46 
Manual%(n) 69.7 (6428) 60.4 (278) 68.5 (680) 70.4 (5470) 0.71** 0.56-0.90 0.60*** 0.49-0.73 
Smoking characteristics          
HSi  M(SD) 2.0 (1.5) 2.2 (1.5) 2.1 (1.5) 2.0 (1.6) 1.07 0.99-1.16 1.11*** 1.04-1.18 
Strength of urges  M(SD) 2.1 (1.1) 2.3 (1.0) 2.2 (1.0) 2.1 (1.1) 1.10 0.98-1.23 1.30*** 1.19-1.42 
Quit attempt in last year %(n) 30.3 (2793) 57.2 (263) 69.1 (684) 23.8 (1846) 0.62*** 0.49-0.79 4.66*** 3.83-5.67 
Trying to cut down cigarettes %(n) 50.6 (4669) 72.4 (333) 87.4 (867) 44.7 (3469) 0.37*** 0.28-0.49 3.33*** 2.70-4.12 
Biopsychosocial prompts to stop (Motives) (max score 6) M(SD) 
Positive smoker identity (identity) (max score 4) M(SD) 
1.6 (1.56) 
2.2 (1.03) 
2.2 (1.72) 
2.0 (1.03) 
2.2 (1.71) 
1.6 (0.98) 
1.5 (1.50) 
2.3 (1.00) 
1.00 
1.47 *** 
0.94-1.07 
1.31-1.65 
1.28*** 
0.74*** 
1.21-1.35 
0.67-0.81 
Individual addiction (Evaluations) (max score2) M(SD) 1.1 (0.71) 1.3 (0.74) 1.1 (0.75) 1.1 (0.71) 1.26 *** 1.08-1.47 1.50*** 1.31-1.73 
Plans to stop (Plans) (max score 2) M(SD) 0.6 (0.57) 0.7 (0.56) 0.7 (0.63) 0.6 (0.56) 1.05 0.87-1.26 1.27**  1.08-1.50 
